Colorectal CancerPhase 3NCT00002575
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
A Phase 3 study testing conventional surgery and laparoscopic surgery in people with Colorectal Cancer, run by Alliance for Clinical Trials in Oncology at 158 sites in 3 countries.
Trial summary
RATIONALE: Less invasive types of surgery may help reduce the number of side effects and improve recovery. It is not yet known which type of surgery is more effective for colon cancer. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Colorectal Cancer
- What is being tested?
- conventional surgery and laparoscopic surgery
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 810 participants
- Where
- 158 sitesin 3 countries
- Study dates
- Aug 1994to Nov 2009
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
DISEASE CHARACTERISTICS:
- Clinical diagnosis of primary adenocarcinoma
- Involving a single colon segment:
- Right colon from the ileocecal valve up to and including the hepatic flexure
- Left colon from the splenic flexure to the junction of the sigmoid and descending colon
- Sigmoid colon between the descending colon and the rectum (at least 15 cm from the dentate)
- Diagnosis based on physical exam plus either a proctosigmoidoscopy and barium enema or a colonoscopy
- No advanced local disease that renders laparoscopic resection impossible
- No acutely obstructed or perforated colon cancer requiring urgent surgery
- No transverse colon cancer (i.e., between distal hepatic flexure and proximal splenic flexure)
- No stage IV disease
- No rectal cancer (i.e., below the peritoneal reflection, lower edge of tumor less than 15 cm from dentate)
- No American Society of Anesthesiologists IV/V disease classification
- No associated gastrointestinal diseases (i.e., Crohn's, chronic ulcerative colitis, or familial polyposis) that require additional extensive operative evaluation or intervention
PATIENT CHARACTERISTICS:
Age:
- 18 and over
Other:
- No other prior or concurrent malignancy within the past 5 years except superficial squamous cell or basal cell skin cancer or carcinoma in situ of the cervix
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY:
Surgery:
- No prohibitive scars/adhesions from prior abdominal surgery
Other:
- No concurrent investigational treatments or invasive diagnostic procedures within 30 days after surgery
Trial locations and contacts
158 sites in 3 countries.
158 sites in 3 countries
United States145 sites
Akron City Hospital
Akron, Ohio, 44309
Albany Regional Cancer Center
Albany, New York, 12208
University of New Mexico Cancer Research & Treatment Center
Albuquerque, New Mexico, 87131
Lehigh Valley Hospital
Allentown, Pennsylvania, 18103
CCOP - Ann Arbor Regional
Ann Arbor, Michigan, 48106
Winship Cancer Institute
Atlanta, Georgia, 30322
CCOP - Atlanta Regional
Atlanta, Georgia, 30342-1701
Medical College of Georgia Comprehensive Cancer Center
Augusta, Georgia, 30912-4000
Franklin Square Hospital Center
Baltimore, Maryland, 21237
Eastern Maine Medical Center
Bangor, Maine, 04401
National Naval Medical Center
Bethesda, Maryland, 20889-5000
St. Luke's Network - Bethlehem
Bethlehem, Pennsylvania, 18015
CCOP - Montana Cancer Consortium
Billings, Montana, 59101
New England Medical Center Hospital
Boston, Massachusetts, 02111
Boston Medical Center
Boston, Massachusetts, 02118
Lahey Clinic - Burlington
Burlington, Massachusetts, 01805
Vermont Cancer Center
Burlington, Vermont, 05401-3498
Aultman Cancer Center
Canton, Ohio, 44710
Lineberger Comprehensive Cancer Center, UNC
Chapel Hill, North Carolina, 27599-7295
Medical University of South Carolina
Charleston, South Carolina, 29425-0721
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, 60611-3013
Veterans Affairs Medical Center - Lakeside Chicago
Chicago, Illinois, 60611
MBCCOP-Cook County Hospital
Chicago, Illinois, 60612
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois, 60612
Illinois Masonic Medical Center
Chicago, Illinois, 60657
Jewish Hospital of Cincinnati, Inc.
Cincinnati, Ohio, 45236
Barrett Cancer Center, The University Hospital
Cincinnati, Ohio, 45267-0502
South Pointe Hospital
Cleveland, Ohio, 44122
Ellis Fischel Cancer Center - Columbia
Columbia, Missouri, 65203
CCOP - Columbus
Columbus, Ohio, 43206
Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, 43210-1240
Medical Group of Texas
Dallas, Texas, 75243
Geisinger Medical Center
Danville, Pennsylvania, 17822-2001
Veterans Affairs Medical Center - Dayton
Dayton, Ohio, 45428
Veterans Affairs Medical Center - Atlanta (Decatur)
Decatur, Georgia, 30033
CCOP - Central Illinois
Decatur, Illinois, 62526
University of Colorado Cancer Center
Denver, Colorado, 80010
CCOP - Colorado Cancer Research Program, Inc.
Denver, Colorado, 80209-5031
CCOP - Iowa Oncology Research Association
Des Moines, Iowa, 50309-1016
Cancer Center and Beckman Research Institute, City of Hope
Duarte, California, 91010-3000
CCOP - Duluth
Duluth, Minnesota, 55805
Michigan State University
East Lansing, Michigan, 48824
Veterans Affairs Medical Center - East Orange
East Orange, New Jersey, 07018-1095
CCOP - Evanston
Evanston, Illinois, 60201
Veterans Affairs Medical Center - Fargo
Fargo, North Dakota, 58102
CCOP - Merit Care Hospital
Fargo, North Dakota, 58122
Regional Cancer Therapy Center - Frederick
Frederick, Maryland, 21701
CCOP - Grand Rapids Clinical Oncology Program
Grand Rapids, Michigan, 49503
CCOP - Green Bay
Green Bay, Wisconsin, 54301
CCOP - Greenville
Greenville, South Carolina, 29615
CCOP - Northern New Jersey
Hackensack, New Jersey, 07601
Hartford Hospital
Hartford, Connecticut, 06102-5037
Cancer Research Center of Hawaii
Honolulu, Hawaii, 96813
Kelsey Seybold Clinic
Houston, Texas, 77025
Huntsville Hospital System
Huntsville, Alabama, 35801-4470
Regional Cancer Center
Indianapolis, Indiana, 46219
Holden Comprehensive Cancer Center
Iowa City, Iowa, 52242-1009
Baptist Regional Cancer Institute - Jacksonville
Jacksonville, Florida, 32207
CCOP - Kalamazoo
Kalamazoo, Michigan, 49007-3731
CCOP - Kansas City
Kansas City, Missouri, 64131
Keesler Medical Center - Keesler AFB
Keesler Air Force Base, Mississippi, 39534-2576
CCOP - Dayton
Kettering, Ohio, 45429
Baptist Regional Cancer Center - Knoxville
Knoxville, Tennessee, 37901
Scripps Clinic
La Jolla, California, 92037
University of California San Diego Cancer Center
La Jolla, California, 92093-0658
Wilford Hall - 59th Medical Wing
Lackland Air Force Base, Texas, 78236-5300
CCOP - Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, 89106
Lucille Parker Markey Cancer Center, University of Kentucky
Lexington, Kentucky, 40536-0093
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
Loma Linda University Medical Center
Loma Linda, California, 92354
Saint Mary Medical Center - Long Beach
Long Beach, California, 90813-0887
Norton Healthcare System
Louisville, Kentucky, 40202-5070
Baptist Hospital East - Louisville
Louisville, Kentucky, 40207
CCOP - North Shore University Hospital
Manhasset, New York, 11030
CCOP - Marshfield Medical Research and Education Foundation
Marshfield, Wisconsin, 54449
Veterans Affairs Medical Center - Memphis
Memphis, Tennessee, 38104
Sylvester Cancer Center, University of Miami
Miami, Florida, 33136
CCOP - Mount Sinai Medical Center
Miami Beach, Florida, 33140
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
Hennepin County Medical Center - Minneapolis
Minneapolis, Minnesota, 55415
MBCCOP - Gulf Coast
Mobile, Alabama, 36688
Louisiana State University Medical Center - New Orleans
New Orleans, Louisiana, 70112
Tulane University School of Medicine
New Orleans, Louisiana, 70112
Veterans Affairs Medical Center - New Orleans
New Orleans, Louisiana, 70112
CCOP - Ochsner
New Orleans, Louisiana, 70121
Newark Beth Israel Medical Center
Newark, New Jersey, 07112
Virginia Oncology Associates - Newport News
Newport News, Virginia, 23606
Eastern Virginia Medical School
Norfolk, Virginia, 23507
West Suburban Hospital Medical Center
Oak Park, Illinois, 60302
CCOP - Bay Area Tumor Institute
Oakland, California, 94609-3305
Naval Medical Center - Oakland
Oakland, California, 94627-5000
CCOP - Missouri Valley Cancer Consortium
Omaha, Nebraska, 68106
Methodist Cancer Center - Omaha
Omaha, Nebraska, 68114
MD Anderson Cancer Center Orlando
Orlando, Florida, 32806
Camden-Clark Memorial Hospital
Parkersburg, West Virginia, 26102
Albert Einstein Cancer Center
Philadelphia, Pennsylvania, 19141
CCOP - Greater Phoenix
Phoenix, Arizona, 85006-2726
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212-4772
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, 15213-3489
Veterans Affairs Medical Center - Pittsburgh
Pittsburgh, Pennsylvania, 15240
Berkshire Medical Center
Pittsfield, Massachusetts, 01201
Champlain Valley Physicians Hospital Medical Center
Plattsburgh, New York, 12901
Oregon Cancer Center
Portland, Oregon, 97201-3098
CCOP - Columbia River Program
Portland, Oregon, 97213
Utah Valley Regional Medical Center - Provo
Provo, Utah, 84604
Reading Hospital and Medical Center
Reading, Pennsylvania, 19612-6052
Veterans Affairs Medical Center - Richmond
Richmond, Virginia, 23249
Massey Cancer Center
Richmond, Virginia, 23298-0037
MBCCOP - Massey Cancer Center
Richmond, Virginia, 23298-0037
Oncology and Hematology Associates of Southwest Virginia, Inc.
Roanoke, Virginia, 24014
Genesee Surgical Associates
Rochester, New York, 14607
Rockford Clinic
Rockford, Illinois, 61103
St. Mary's Hospital
Rogers, Arkansas, 72756
Sutter Cancer Center
Sacramento, California, 95816
Veterans Affairs Satellite Clinic - Sacramento
Sacramento, California, 95820
CCOP - Metro-Minnesota
Saint Louis Park, Minnesota, 55416
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78284-7811
Naval Medical Center - San Diego
San Diego, California, 92134-3202
Veterans Affairs Medical Center - San Francisco
San Francisco, California, 94121
CCOP - Santa Rosa Memorial Hospital
Santa Rosa, California, 95403
Sarasota Memorial Hospital
Sarasota, Florida, 34239
CCOP - Virginia Mason Research Center
Seattle, Washington, 98101
Puget Sound Oncology Consortium
Seattle, Washington, 98109
CCOP - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, 57104
Providence Hospital - Southfield
Southfield, Michigan, 48075-9975
CCOP - Upstate Carolina
Spartanburg, South Carolina, 29303
Baystate Medical Center
Springfield, Massachusetts, 01199
St. Louis University School of Medicine
St Louis, Missouri, 63104
CCOP - St. Louis-Cape Girardeau
St Louis, Missouri, 63141
Staten Island University Hospital
Staten Island, New York, 10305
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
Syracuse, New York, 13217
CCOP - Northwest
Tacoma, Washington, 98405-0986
CCOP - Toledo Community Hospital Oncology Program
Toledo, Ohio, 43623-3456
CCOP - Oklahoma
Tulsa, Oklahoma, 74136
University of Texas Health Center at Tyler
Tyler, Texas, 75708
CCOP - Carle Cancer Center
Urbana, Illinois, 61801
Kaiser Permanente Medical Center - Vallejo
Vallejo, California, 94589
Kent County Memorial Hospital
Warwick, Rhode Island, 02886
CCOP - Wichita
Wichita, Kansas, 67214-3882
CCOP - Christiana Care Health Services
Wilmington, Delaware, 19899
CCOP - Southeast Cancer Control Consortium
Winston-Salem, North Carolina, 27104-4241
Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, 27157-1082
University of Massachusetts Memorial Healthcare
Worester, Massachusetts, 01605
CCOP - MainLine Health
Wynnewood, Pennsylvania, 19096
York Hospital
York, Pennsylvania, 17315
Canada11 sites
Tom Baker Cancer Center - Calgary
Calgary, Alberta, T2N 4N2
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2
Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, H2L-4M1
Royal Victoria Hospital - Montreal
Montreal, Quebec, H3A 1A1
Montreal General Hospital
Montreal, Quebec, H3G 1A4
Jewish General Hospital - Montreal
Montreal, Quebec, H3T 1E2
Centre Hospitalier Universitaire de Quebec
Québec, Quebec, G1R 2J6
L'Hopital Laval
Ste-Foy, Quebec, G1V 4G5
Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, M4N 3M5
St. Michael's Hospital - Toronto
Toronto, Ontario, M5B 1W8
CancerCare Manitoba
Winnipeg, Manitoba, R3E 0V9
Puerto Rico2 sites
MBCCOP - San Juan
San Juan, 00927-5800
Veterans Affairs Medical Center - San Juan
San Juan, 00927-5800
About this study
Official title: A PHASE III PROSPECTIVE RANDOMIZED TRIAL COMPARING LAPAROSCOPIC-ASSISTED COLECTOMY VERSUS OPEN COLECTOMY FOR COLON CANCER
RATIONALE: Less invasive types of surgery may help reduce the number of side effects and improve recovery. It is not yet known which type of surgery is more effective for colon cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of laparoscopic-assisted colectomy with open colectomy in treating patients who have colon cancer.
Read the detailed description
OBJECTIVES:
- Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy.
- Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients.
- Compare the differences in costs and cost effectiveness between these treatments in this patient population.
- Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99)
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center, primary surgeon, site of primary tumor (right vs left vs sigmoid), and American Society of Anesthesiologists disease classification (I and II vs III). Patients are randomized to one of two treatment arms.
The extent of colon resection is identical for both arms.
- Conditions
- Colorectal Cancer
- Being tested
- conventional surgery, laparoscopic surgery
- Keywords
- stage I colon cancer, stage II colon cancer, stage III colon cancer, adenocarcinoma of the colon
- Medical subject headings
- Colorectal Neoplasms, Colonic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
conventional surgeryProcedure or surgery
laparoscopic surgeryProcedure or surgery
| Study group | Role | What they receive |
|---|---|---|
| Conventional surgery | Experimental | Patients undergo open laparotomy and colectomy. A standard incision is made through the abdominal wall and the abdominal cavity is explored. A right or left colectomy or a sigmoid resection is performed.
Patients may be entered on adjuvant chemotherapy trials after surgery provided the subsequent trial does not include radiotherapy and allows entry of patients from both arms.
Quality of life is assessed at baseline and on days 2 and 14 after surgery, at 2 months, and then at 18 months. (closed as of 4/30/99)
Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually for 3 years. Receives: Procedure: conventional surgery |
| Laparoscopic-assisted colectomy | Experimental | Patients undergo a laparoscopic-assisted colectomy. A small infraumbilical incision is made through the abdominal skin and the abdominal cavity is insufflated with CO2 to allow access and visualization. The abdominal cavity is explored. If advanced local disease is identified, a celiotomy and colectomy are performed. Otherwise, a right or left colectomy or sigmoid resection is performed using laparoscopic-assisted techniques.
Patients may be entered on adjuvant chemotherapy trials after surgery provided the subsequent trial does not include radiotherapy and allows entry of patients from both arms.
Quality of life is assessed at baseline and on days 2 and 14 after surgery, at 2 months, and then at 18 months. (closed as of 4/30/99)
Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually for 3 years. Receives: Procedure: laparoscopic surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Disease-free survival
- Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy.
- Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients.
- Compare the differences in costs and cost effectiveness between these treatments in this patient population.
- Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99)
Measured: Up to 8 years
Overall survival
Measured: Up to 8 years
Secondary outcomes (4)
Morbidity
Measured: Up to 8 years
Mortality
Measured: At 30 days
Costs and cost effectiveness between these treatments in this patient population
Measured: Up to 8 years
Compare the differences in quality of life of patients treated with these regimens
Measured: Up to 8 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Apr 2003 (estimated)
- Study startAug 1994
- Primary completionMay 2004
- Study completionNov 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Colorectal CancerStudies of the same condition, open and under way.
- More trials run by Alliance for Clinical Trials in OncologyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 810 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI), NCIC Clinical Trials Group
- Responsible party
- Sponsor
- Investigators
- Heidi Nelson, MD, Study chair, Mayo Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00002575
- Sponsor's protocol ID
- NCCTG-934653
- Other IDs
- NCI-2012-02234, CAN-NCIC-CO12, CDR0000063648
- Status last verified
- Jul 2016
- First submitted
- 1 Nov 1999
- Last updated
- 18 Jul 2016
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Stucky CC, Pockaj BA, Novotny PJ, Sloan JA, Sargent DJ, O'Connell MJ, Beart RW, Skibber JM, Nelson H, Weeks JC. Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Ann Surg Oncol. 2011 Sep;18(9):2422-31. doi: 10.1245/s10434-011-1650-2. Epub 2011 Mar 31.
PubMed 21452066Larson DW, Marcello PW, Larach SW, Wexner SD, Park A, Marks J, Senagore AJ, Thorson AG, Young-Fadok TM, Green E, Sargent DJ, Nelson H. Surgeon volume does not predict outcomes in the setting of technical credentialing: results from a randomized trial in colon cancer. Ann Surg. 2008 Nov;248(5):746-50. doi: 10.1097/SLA.0b013e31818a157d.
PubMed 18948801Clinical Outcomes of Surgical Therapy Study Group; Nelson H, Sargent DJ, Wieand HS, Fleshman J, Anvari M, Stryker SJ, Beart RW Jr, Hellinger M, Flanagan R Jr, Peters W, Ota D. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004 May 13;350(20):2050-9. doi: 10.1056/NEJMoa032651.
PubMed 15141043Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G; Clinical Outcomes of Surgical Therapy (COST) Study Group. Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA. 2002 Jan 16;287(3):321-8. doi: 10.1001/jama.287.3.321.
PubMed 11790211
Study at a glance
From the registry record, last updated by the sponsor on 18 Jul 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A PHASE III PROSPECTIVE RANDOMIZED TRIAL COMPARING LAPAROSCOPIC-ASSISTED COLECTOMY VERSUS OPEN COLECTOMY FOR COLON CANCER
- ClinicalTrials.gov ID
- NCT00002575
- Acronym / sponsor ID
- NCCTG-934653
- Conditions
- Colorectal Cancer
- Keywords
- stage I colon cancer, stage II colon cancer, stage III colon cancer, adenocarcinoma of the colon
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 810 participants (actual)
- Lead sponsor
- Alliance for Clinical Trials in OncologyUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI), NCIC Clinical Trials Group
- Study start
- Aug 1994
- Primary completion
- May 2004 (actual)
- Study completion
- Nov 2009 (actual)
- First posted
- 10 Apr 2003 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
RATIONALE: Less invasive types of surgery may help reduce the number of side effects and improve recovery. It is not yet known which type of surgery is more effective for colon cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of laparoscopic-assisted colectomy with open colectomy in treating patients who have colon cancer.
Detailed description
OBJECTIVES:
- Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy.
- Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients.
- Compare the differences in costs and cost effectiveness between these treatments in this patient population.
- Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99)
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center, primary surgeon, site of primary tumor (right vs left vs sigmoid), and American Society of Anesthesiologists disease classification (I and II vs III). Patients are randomized to one of two treatment arms.
The extent of colon resection is identical for both arms.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Conventional surgery | Experimental | Procedure: conventional surgeryPatients undergo open laparotomy and colectomy. A standard incision is made through the abdominal wall and the abdominal cavity is explored. A right or left colectomy or a sigmoid resection is performed. Patients may be entered on adjuvant chemotherapy trials after surgery provided the subsequent trial does not include radiotherapy and allows entry of patients from both arms. Quality of life is assessed at baseline and on days 2 and 14 after surgery, at 2 months, and then at 18 months. (closed as of 4/30/99) Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually for 3 years. |
| Laparoscopic-assisted colectomy | Experimental | Procedure: laparoscopic surgeryPatients undergo a laparoscopic-assisted colectomy. A small infraumbilical incision is made through the abdominal skin and the abdominal cavity is insufflated with CO2 to allow access and visualization. The abdominal cavity is explored. If advanced local disease is identified, a celiotomy and colectomy are performed. Otherwise, a right or left colectomy or sigmoid resection is performed using laparoscopic-assisted techniques. Patients may be entered on adjuvant chemotherapy trials after surgery provided the subsequent trial does not include radiotherapy and allows entry of patients from both arms. Quality of life is assessed at baseline and on days 2 and 14 after surgery, at 2 months, and then at 18 months. (closed as of 4/30/99) Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually for 3 years. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| conventional surgery | Procedure or surgery | Conventional surgery |
| laparoscopic surgery | Procedure or surgery | Laparoscopic-assisted colectomy |
Primary outcome
Disease-free survival
Time frame: Up to 8 years
* Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy. * Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients. * Compare the differences in costs and cost effectiveness between these treatments in this patient population. * Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99)
Overall survival
Time frame: Up to 8 years
4 secondary outcomes
Morbidity
Time frame: Up to 8 years
Mortality
Time frame: At 30 days
Costs and cost effectiveness between these treatments in this patient population
Time frame: Up to 8 years
Compare the differences in quality of life of patients treated with these regimens
Time frame: Up to 8 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jul 2016.
- Results publication: PubMed 21452066Stucky CC, Pockaj BA, Novotny PJ, Sloan JA, Sargent DJ, O'Connell MJ, Beart RW, Skibber JM, Nelson H, Weeks JC. Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Ann Surg Oncol. 2011 Sep;18(9):2422-31. doi: 10.1245/s10434-011-1650-2. Epub 2011 Mar 31.
- Results publication: PubMed 18948801Larson DW, Marcello PW, Larach SW, Wexner SD, Park A, Marks J, Senagore AJ, Thorson AG, Young-Fadok TM, Green E, Sargent DJ, Nelson H. Surgeon volume does not predict outcomes in the setting of technical credentialing: results from a randomized trial in colon cancer. Ann Surg. 2008 Nov;248(5):746-50. doi: 10.1097/SLA.0b013e31818a157d.
- Results publication: PubMed 15141043Clinical Outcomes of Surgical Therapy Study Group; Nelson H, Sargent DJ, Wieand HS, Fleshman J, Anvari M, Stryker SJ, Beart RW Jr, Hellinger M, Flanagan R Jr, Peters W, Ota D. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004 May 13;350(20):2050-9. doi: 10.1056/NEJMoa032651.
- Results publication: PubMed 11790211Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G; Clinical Outcomes of Surgical Therapy (COST) Study Group. Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA. 2002 Jan 16;287(3):321-8. doi: 10.1001/jama.287.3.321.
Related trials for Colorectal Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingObservational study
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Colorectal Neoplasms, Gastric Neoplasms
Not yet recruitingPhase 2
Phase II Clinical Study of RC148 (ABBV-1480) in Combination With Telisotuzumab Adizutecan (With or Without Chemotherapy) for Unresectable Colorectal Cancer
Patients With Unresectable Colorectal Cancer Requiring First-Line or Second-Line Therapy
RecruitingPhase 1
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Breast Neoplasms, Colorectal Neoplasms
Active, not recruitingPhase 3
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Heidi Nelson, MD study chair
Mayo Clinic
158 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing conventional surgery and laparoscopic surgery in people with Colorectal Cancer, run by Alliance for Clinical Trials in Oncology at 158 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 158 sites in United States, Canada, Puerto Rico. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Disease-free survival (time frame: Up to 8 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00002575, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2016.